{"id":"https://openalex.org/W3136690647","doi":"https://doi.org/10.1016/j.jtho.2021.01.891","title":"P48.21 Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN","display_name":"P48.21 Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN","publication_year":2021,"publication_date":"2021-03-01","ids":{"openalex":"https://openalex.org/W3136690647","doi":"https://doi.org/10.1016/j.jtho.2021.01.891","mag":"3136690647"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtho.2021.01.891","doi":"https://doi.org/10.1016/j.jtho.2021.01.891","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtho.2021.01.891","pdf_url":null,"source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jtho.2021.01.891","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Y. Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Zheng","raw_affiliation_strings":["Astrazeneca, San Francisco/CA/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, San Francisco/CA/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Jin","raw_affiliation_strings":["Astrazeneca, San Francisco/CA/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, San Francisco/CA/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111346827","display_name":"Y. Guan","orcid":"https://orcid.org/0000-0001-6446-7767","observed_orcids":["https://orcid.org/0000-0001-6446-7767"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Guan","raw_affiliation_strings":["Astrazeneca, San Francisco/CA/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, San Francisco/CA/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023874099","display_name":"Mustafa \u00d6zg\u00fcro\u011flu","orcid":"https://orcid.org/0000-0002-8417-8628","observed_orcids":["https://orcid.org/0000-0002-8417-8628"]},"institutions":[{"id":"https://openalex.org/I4210112471","display_name":"Istanbul University-Cerrahpa\u015fa","ror":"https://ror.org/01dzn5f42","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210112471"]},{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"M. \u00d6zg\u00fcro\u011flu","raw_affiliation_strings":["Istanbul University-Cerrahpa\u015fa, Cerrahpa\u015fa School of Medicine, Istanbul/TR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University-Cerrahpa\u015fa, Cerrahpa\u015fa School of Medicine, Istanbul/TR","institution_ids":["https://openalex.org/I4210112471","https://openalex.org/I67581229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071555124","display_name":"Dmytro V. Trukhin","orcid":"https://orcid.org/0009-0006-3412-0758","observed_orcids":["https://orcid.org/0009-0006-3412-0758"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Trukhin","raw_affiliation_strings":["Odessa Regional Oncological Dispensary, Odessa/UA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Odessa Regional Oncological Dispensary, Odessa/UA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084070841","display_name":"Artem Poltoratskiy","orcid":"https://orcid.org/0000-0003-3259-2242","observed_orcids":["https://orcid.org/0000-0003-3259-2242","https://orcid.org/0000-0002-7650-1122"]},"institutions":[{"id":"https://openalex.org/I4210116304","display_name":"Institute of Oncology NN Petrov","ror":"https://ror.org/01mfpjp46","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210116304","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Poltoratskiy","raw_affiliation_strings":["Petrov Research Institute of Oncology, St Petersburg/RU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Petrov Research Institute of Oncology, St Petersburg/RU","institution_ids":["https://openalex.org/I4210116304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422490","display_name":"Yuanbin Chen","orcid":"https://orcid.org/0009-0006-4175-8055","observed_orcids":["https://orcid.org/0009-0006-4175-8055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Chen","raw_affiliation_strings":["Cancer and Hematology Centers of Western Michigan, Grand Rapids/MI/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer and Hematology Centers of Western Michigan, Grand Rapids/MI/US","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007665505","display_name":"Libor Havel","orcid":"https://orcid.org/0009-0007-9131-226X","observed_orcids":["https://orcid.org/0009-0007-9131-226X"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210144209","display_name":"Thomayer University Hospital","ror":"https://ror.org/04hyq8434","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210144209"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"L. Havel","raw_affiliation_strings":["Thomayer Hospital, First Faculty of Medicine, Charles University, Prague/CZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomayer Hospital, First Faculty of Medicine, Charles University, Prague/CZ","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210144209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012226414","display_name":"Maximilian Johannes Hochmair","orcid":"https://orcid.org/0000-0002-8673-2450","observed_orcids":["https://orcid.org/0000-0002-8673-2450"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Hochmair","raw_affiliation_strings":["Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna/AT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna/AT","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083563755","display_name":"Luiz Paz-Ares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121748325","display_name":"Universidad Complutense de Madrid","ror":"https://ror.org/02p0gd045","country_code":"ES","type":"education","lineage":["https://openalex.org/I121748325"]},{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"L. Paz-Ares","raw_affiliation_strings":["Hospital Universitario 12 de Octubre, H120-Cnio Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid/ES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre, H120-Cnio Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid/ES","institution_ids":["https://openalex.org/I121748325","https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061878462","display_name":"Haiyi Jiang","orcid":"https://orcid.org/0009-0002-8677-6821","observed_orcids":["https://orcid.org/0009-0002-8677-6821"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Jiang","raw_affiliation_strings":["Astrazeneca, Gaithersburg/MD/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, Gaithersburg/MD/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081263517","display_name":"Jon M. Armstrong","orcid":"https://orcid.org/0009-0008-2292-1835","observed_orcids":["https://orcid.org/0009-0008-2292-1835"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Armstrong","raw_affiliation_strings":["Astrazeneca, Cambridge/GB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, Cambridge/GB","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Chen","raw_affiliation_strings":["Astrazeneca, San Francisco/CA/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, San Francisco/CA/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y.H. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y.H. Liu","raw_affiliation_strings":["Astrazeneca, Gaithersburg/MD/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, Gaithersburg/MD/US","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069627913","display_name":"Lorin K. Roskos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Roskos","raw_affiliation_strings":["Astrazeneca, San Francisco/CA/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, San Francisco/CA/US","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"3","first_page":"S508","last_page":"S508"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.8560000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.8560000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0640999972820282,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03200000151991844,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.781000018119812},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/caspian-trial","display_name":"CASPIAN trial","score":0.8230000138282776},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.7730000019073486},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8968916535377502},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.8775540590286255},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7232394218444824},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7045938372612},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6263482570648193},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5596120357513428},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5273098945617676},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5091449618339539},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4974830448627472},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.48705318570137024},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4499555230140686},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4418225884437561},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.44053179025650024},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3399994373321533},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.297597736120224},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2878077030181885},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18551206588745117},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.08616328239440918},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.0},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtho.2021.01.891","doi":"https://doi.org/10.1016/j.jtho.2021.01.891","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtho.2021.01.891","pdf_url":null,"source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtho.2021.01.891","doi":"https://doi.org/10.1016/j.jtho.2021.01.891","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtho.2021.01.891","pdf_url":null,"source":{"id":"https://openalex.org/S90745127","display_name":"Journal of Thoracic Oncology","issn_l":"1556-0864","issn":["1556-0864","1556-1380"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Thoracic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3202775595","https://openalex.org/W4293148176","https://openalex.org/W3138062918","https://openalex.org/W2981937139","https://openalex.org/W3207715423","https://openalex.org/W3031958079","https://openalex.org/W4220970211","https://openalex.org/W4294935530","https://openalex.org/W3183172574","https://openalex.org/W2989683368"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2021-03-29T00:00:00"}